Why Imprivata (IMPR) Stock Is Soaring Today
NEW YORK (TheStreet) -- Shares of Imprivata (IMPR) are spiking 31.21% to $19.02 on heavy trading volume early Wednesday afternoon after agreeing to be purchased by private-equity firm Thoma Bravo for roughly $544 million.
Shareholders of the healthcare IT security company will receive $19.25 in cash per share of Imprivata, representing a 33% premium to the stock's closing price of $14.50 on Tuesday.
"We are now in a stronger position to pursue market opportunities through innovating and expanding the products and services we offer," Imprivata CEO Omar Hussain said in a statement.
About 4.07 million shares of Imprivata have been traded so far today, well above its average trading volume of roughly 162,682 shares per day.
Separately, TheStreet Ratings team rates the stock as a "sell" with a ratings score of D.
Imprivata's weaknesses include its disappointing return on equity and generally disappointing historical performance in the stock itself.
You can view the full analysis from the report here: IMPR
TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this article's author.